Skip to main content

Together we are beating cancer

Donate now

Treatment

Showing 12 out of 1202 results
Cancer Research UK scientists in the lab

NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation. NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation.

by Tim Gunn | News | 13 June 2024

13 June 2024

People at a party wearing party hats

In this third and final article in this special series about our PPI project ‘How can we share research together? A co-creation project to make scientific research more accessible’ we hear from one of the patient representatives who took part in the project, Holly Spencer. Here Holly reflects on her diagnosis, her interest in patient and public involvement and her experience of being part of this project. In this third and final article in this special series about our PPI project ‘How can we share research together? A co-creation project to make scientific research more accessible’ we hear from one of the patient representatives who took part in the project, Holly Spencer. Here Holly reflects on her diagnosis, her interest in patient and public involvement and her experience of being part of this project.

by Holly Spencer | Personal stories | 11 June 2024

11 June 2024

This entry is part 3 of 3 in the series How can we share research together?
An informational sheet highlighting how radiotherapy can be used to make radiotherapy in children more precise

A graphic designer shares their perspective on a recent patient and public involvement project during which an accessible information sheet based on a journal paper was co-created A graphic designer shares their perspective on a recent patient and public involvement project during which an accessible information sheet based on a journal paper was co-created

by Gill Brown | Analysis | 4 June 2024

4 June 2024

This entry is part 2 of 3 in the series How can we share research together?
A medical professional drawing a dose of a vaccine from a vial with a syringe

Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service

by Jacob Smith | News | 31 May 2024

31 May 2024

Artwork produced as part of a patient and public involvement workshop

In this mini-series of three articles, we share a recent PPIE project where we co-created an accessible information sheet based on a journal paper. In this article the PPI co-ordinator, Lisa Whittaker and one of the researchers, Catarina Veiga give an overview of the project and share their experiences of being involved. In this mini-series of three articles, we share a recent PPIE project where we co-created an accessible information sheet based on a journal paper. In this article the PPI co-ordinator, Lisa Whittaker and one of the researchers, Catarina Veiga give an overview of the project and share their experiences of being involved.

by Lisa Whittaker, Catarina Veiga | Analysis | 28 May 2024

28 May 2024

This entry is part 1 of 3 in the series How can we share research together?
Issy, Jake and Joram, who shared their stories with us for Teenage and Young Adult Cancer Awareness Month.

April is Teenage and Young Adult Cancer Awareness Month. Three teenagers who were diagnosed with cancer share their experiences and advice. April is Teenage and Young Adult Cancer Awareness Month. Three teenagers who were diagnosed with cancer share their experiences and advice.

by Tom Bourton, Tim Gunn | Personal stories | 2 April 2024

2 April 2024

Endometrial adenocarcinoma cells viewed under the microscope

Dostarlimab (also called Jemperli) has been recommended by the National Institute of Health and Care Excellence (NICE) to treat some types of advanced or recurrent womb cancer Dostarlimab (also called Jemperli) has been recommended by the National Institute of Health and Care Excellence (NICE) to treat some types of advanced or recurrent womb cancer

by Jacob Smith | News | 8 March 2024

8 March 2024

A close up of the UK on a globe, with a red pin marking its location

New research from the International Cancer Benchmarking Partnership shows people in the UK were treated with chemotherapy and radiotherapy less often, and faced longer waits to start treatment New research from the International Cancer Benchmarking Partnership shows people in the UK were treated with chemotherapy and radiotherapy less often, and faced longer waits to start treatment

by Jacob Smith | Analysis | 27 February 2024

27 February 2024

Infusion pump feeding IV drip into patients arm

Some people with cancer in the UK are struggling more than others to get access to treatment. But what is causing this unwarranted variation in access to treatment, and how can we makes things better? Some people with cancer in the UK are struggling more than others to get access to treatment. But what is causing this unwarranted variation in access to treatment, and how can we makes things better?

by Emily Eagles, Lyndsy Ambler | Analysis | 23 February 2024

23 February 2024